Ihle, Nathan T.
Pfizer (United States)
2 papers on CoChatORCID 0009-0006-2991-2742
Most cited papers
- Verified
Effect of KRAS Oncogene Substitutions on Protein Behavior: Implications for Signaling and Clinical Outcome
Ihle, N. T., Byers, L. A., Kim, E. S., Saintigny, P., Lee, J. J., Blumenschein, G. R., Tsao, A., Liu, S., Larsen, J. E., Wang, J., et al. (2012) · JNCI: Journal of the National Cancer Institute
Lung Cancer Treatments and MutationsProtein Kinase Regulation and GTPase Signaling
Cited by 532
- Verified
Chemical Proteomics Identifies Druggable Vulnerabilities in a Genetically Defined Cancer
Bar-Peled, L., Kemper, E. K., Suciu, R. M., Vinogradova, E. V., Backus, K. M., Horning, B. D., Paul, T. A., Ichu, T.-A., Svensson, R. U., Olucha, J., et al. (2017) · Cell
Genomics, phytochemicals, and oxidative stressLung Cancer Treatments and Mutations
Cited by 262
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free